Published in Sci Transl Med on July 25, 2012
mTOR is a key modulator of ageing and age-related disease. Nature (2013) 5.40
mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science (2013) 3.41
When lamins go bad: nuclear structure and disease. Cell (2013) 1.84
Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res (2014) 1.59
New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53-/- mice by delaying carcinogenesis. Aging (Albany NY) (2012) 1.47
Drugs that modulate aging: the promising yet difficult path ahead. Transl Res (2013) 1.38
Weekly administration of rapamycin improves survival and biomarkers in obese male mice on high-fat diet. Aging Cell (2014) 1.27
Broken nuclei--lamins, nuclear mechanics, and disease. Trends Cell Biol (2013) 1.25
Dual mTORC1/C2 inhibitors suppress cellular geroconversion (a senescence program). Oncotarget (2015) 1.23
Rapamycin extends life- and health span because it slows aging. Aging (Albany NY) (2013) 1.19
Rejuvenating immunity: "anti-aging drug today" eight years later. Oncotarget (2015) 1.13
Common drugs and treatments for cancer and age-related diseases: revitalizing answers to NCI's provocative questions. Oncotarget (2012) 1.11
The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging. Cell Metab (2016) 1.10
Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycin. Cancer Biol Ther (2014) 1.08
Skeletal muscle, autophagy, and physical activity: the ménage à trois of metabolic regulation in health and disease. J Mol Med (Berl) (2013) 1.07
Modeling of lamin A/C mutation premature cardiac aging using patient‐specific induced pluripotent stem cells. Aging (Albany NY) (2012) 1.00
Aging and Autophagy in the Heart. Circ Res (2016) 1.00
mTORC1 and p53: clash of the gods? Cell Cycle (2013) 0.98
mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy. Hum Mol Genet (2012) 0.96
Defective autophagy and mTORC1 signaling in myotubularin null mice. Mol Cell Biol (2012) 0.95
Prelamin A accumulation and stress conditions induce impaired Oct-1 activity and autophagy in prematurely aged human mesenchymal stem cell. Aging (Albany NY) (2014) 0.95
Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion. Oncotarget (2014) 0.94
mTOR Inhibition: From Aging to Autism and Beyond. Scientifica (Cairo) (2013) 0.94
Rapamycin decreases DNA damage accumulation and enhances cell growth of WRN-deficient human fibroblasts. Aging Cell (2014) 0.94
Mitochondrial Quality Control and Muscle Mass Maintenance. Front Physiol (2016) 0.92
Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice. Elife (2016) 0.92
Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo. Cell Cycle (2013) 0.91
Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice. J Gerontol A Biol Sci Med Sci (2016) 0.90
Rapamycin treatment of Mandibuloacral dysplasia cells rescues localization of chromatin-associated proteins and cell cycle dynamics. Aging (Albany NY) (2014) 0.90
Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice. Front Genet (2015) 0.90
Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutation. J Biol Chem (2012) 0.89
Titin-truncating variants affect heart function in disease cohorts and the general population. Nat Genet (2016) 0.88
Sex- and tissue-specific changes in mTOR signaling with age in C57BL/6J mice. Aging Cell (2015) 0.88
Rapamycin, anti-aging, and avoiding the fate of Tithonus. J Clin Invest (2013) 0.88
Gerosuppression in confluent cells. Aging (Albany NY) (2014) 0.87
p62 expression and autophagy in αB-crystallin R120G mutant knock-in mouse model of hereditary cataract. Exp Eye Res (2013) 0.87
Comparison of rapamycin schedules in mice on high-fat diet. Cell Cycle (2014) 0.87
Fasting levels of hepatic p-S6 are increased in old mice. Cell Cycle (2014) 0.86
The intriguing regulators of muscle mass in sarcopenia and muscular dystrophy. Front Aging Neurosci (2014) 0.86
The nuclear envelope: an intriguing focal point for neurogenetic disease. Neurotherapeutics (2014) 0.86
Denervation atrophy is independent from Akt and mTOR activation and is not rescued by myostatin inhibition. Dis Model Mech (2014) 0.85
Skeletal Muscle Laminopathies: A Review of Clinical and Molecular Features. Cells (2016) 0.85
MicroRNA-221 inhibits autophagy and promotes heart failure by modulating the p27/CDK2/mTOR axis. Cell Death Differ (2014) 0.84
Causes and consequences of nuclear envelope alterations in tumour progression. Eur J Cell Biol (2016) 0.83
MTOR-driven quasi-programmed aging as a disposable soma theory: blind watchmaker vs. intelligent designer. Cell Cycle (2013) 0.82
Myopathic lamin mutations cause reductive stress and activate the nrf2/keap-1 pathway. PLoS Genet (2015) 0.82
Rapamycin Increases Mortality in db/db Mice, a Mouse Model of Type 2 Diabetes. J Gerontol A Biol Sci Med Sci (2015) 0.82
A filtering strategy identifies FOXQ1 as a potential effector of lamin A dysfunction. Aging (Albany NY) (2012) 0.82
GENETIC CAUSES OF DILATED CARDIOMYOPATHY. Prog Pediatr Cardiol (2014) 0.82
Four-week rapamycin treatment improves muscular dystrophy in a fukutin-deficient mouse model of dystroglycanopathy. Skelet Muscle (2016) 0.80
The role of mTOR signalling in the regulation of skeletal muscle mass in a rodent model of resistance exercise. Sci Rep (2016) 0.80
Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island. J Gerontol A Biol Sci Med Sci (2016) 0.80
Aberrant mTOR activation in senescence and aging: A mitochondrial stress response? Exp Gerontol (2014) 0.79
Histone modifications change with age, dietary restriction and rapamycin treatment in mouse brain. Oncotarget (2015) 0.78
Oxidative stress and antioxidant response in fibroblasts from Werner and atypical Werner syndromes. Aging (Albany NY) (2014) 0.78
Antioxidant Treatment and Induction of Autophagy Cooperate to Reduce Desmin Aggregation in a Cellular Model of Desminopathy. PLoS One (2015) 0.78
Nuclear envelope protein Lem2 is required for mouse development and regulates MAP and AKT kinases. PLoS One (2015) 0.78
Ligands for FKBP12 increase Ca2+ influx and protein synthesis to improve skeletal muscle function. J Biol Chem (2014) 0.78
Lamin in inflammation and aging. Curr Opin Cell Biol (2016) 0.78
Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond. Cold Spring Harb Perspect Med (2016) 0.78
Nuclear lamins and oxidative stress in cell proliferation and longevity. Adv Exp Med Biol (2014) 0.77
mTOR signaling plays a critical role in the defects observed in muscle-derived stem/progenitor cells isolated from a murine model of accelerated aging. J Orthop Res (2016) 0.76
"Get the Balance Right": Pathological Significance of Autophagy Perturbation in Neuromuscular Disorders. J Neuromuscul Dis (2016) 0.76
Rapamycin Attenuates Age-associated Changes in Tibialis Anterior Tendon Viscoelastic Properties. J Gerontol A Biol Sci Med Sci (2016) 0.76
Zebrafish ambra1a and ambra1b knockdown impairs skeletal muscle development. PLoS One (2014) 0.76
In silico investigation of potential mTOR inhibitors from traditional Chinese medicine for treatment of Leigh syndrome. Biomed Res Int (2014) 0.75
From rapalogs to anti-aging formula. Oncotarget (2017) 0.75
Progeria: a rare genetic premature ageing disorder. Indian J Med Res (2014) 0.75
Mammalian Target of Rapamycin: A Target for (Lung) Diseases and Aging. Ann Am Thorac Soc (2016) 0.75
The "tail" of Connexin43: An unexpected journey from alternative translation to trafficking. Biochim Biophys Acta (2015) 0.75
Genetic Variations Leading to Familial Dilated Cardiomyopathy. Mol Cells (2016) 0.75
Current insights into LMNA cardiomyopathies: Existing models and missing LINCs. Nucleus (2017) 0.75
Disrupted autophagy undermines skeletal muscle adaptation and integrity. Mamm Genome (2016) 0.75
Deletion of MLIP (Muscle-enriched A-type Lamin-interacting Protein) Leads to Cardiac Hyperactivation of Akt/Mammalian Target of Rapamycin (mTOR) and Impaired Cardiac Adaptation. J Biol Chem (2015) 0.75
Finding Ponce de Leon's Pill: Challenges in Screening for Anti-Aging Molecules. F1000Res (2016) 0.75
Gerosuppression by pan-mTOR inhibitors. Aging (Albany NY) (2016) 0.75
De novo RRAGC mutation activates mTORC1 signaling in syndromic fetal dilated cardiomyopathy. Hum Genet (2016) 0.75
Progeroid syndrome patients with ZMPSTE24 deficiency could benefit when treated with rapamycin and dimethylsulfoxide. Cold Spring Harb Mol Case Stud (2017) 0.75
PIP3-binding proteins promote age-dependent protein aggregation and limit survival in C. elegans. Oncotarget (2016) 0.75
Proteostasis in cardiac health and disease. Nat Rev Cardiol (2017) 0.75
Dilated Cardiomyopathy: Genetic Determinants and Mechanisms. Circ Res (2017) 0.75
LMNA Sequences of 60,706 Unrelated Individuals Reveal 132 Novel Missense Variants in A-Type Lamins and Suggest a Link between Variant p.G602S and Type 2 Diabetes. Front Genet (2017) 0.75
The Inhibitory Effect of WenxinKeli on H9C2 Cardiomyocytes Hypertrophy Induced by Angiotensin II through Regulating Autophagy Activity. Oxid Med Cell Longev (2017) 0.75
mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol (2010) 21.16
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature (2009) 19.56
Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J Cell Biol (2005) 18.60
mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell (2002) 18.22
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol (2011) 15.71
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell (2002) 11.50
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol (2001) 10.85
Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2. PLoS Biol (2009) 9.63
FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab (2007) 8.90
RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc Natl Acad Sci U S A (1998) 8.03
Lamin a truncation in Hutchinson-Gilford progeria. Science (2003) 8.01
Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol (1999) 7.65
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol (2001) 6.71
Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med (1999) 5.61
Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci (2010) 5.54
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest (2005) 5.48
GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. Mol Cell (2003) 5.21
Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet (1999) 5.04
mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells. Sci Signal (2009) 3.94
Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation (2004) 3.35
Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet (2000) 3.08
Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration. Nat Med (2010) 3.01
Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie (2007) 2.95
The TOR pathway comes of age. Biochim Biophys Acta (2009) 2.83
Regulation of eIF-4E BP1 phosphorylation by mTOR. J Biol Chem (1997) 2.73
Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest (2004) 2.67
Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet (2000) 2.52
Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am Heart J (2008) 2.48
Unique properties of lamp2a compared to other lamp2 isoforms. J Cell Sci (2000) 2.46
Autophagy and p62 in cardiac proteinopathy. Circ Res (2011) 2.24
Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet (2002) 2.20
Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy. Mol Biol Cell (2008) 2.14
Alteration of nuclear lamin organization inhibits RNA polymerase II-dependent transcription. J Cell Biol (2002) 2.14
The role of the cytoskeleton in heart failure. Cardiovasc Res (2000) 1.98
Long-term outcome and risk stratification in dilated cardiolaminopathies. J Am Coll Cardiol (2008) 1.97
Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. J Clin Invest (2011) 1.84
Disruption of nuclear lamin organization blocks the elongation phase of DNA replication. J Cell Biol (2000) 1.64
A progeria mutation reveals functions for lamin A in nuclear assembly, architecture, and chromosome organization. Proc Natl Acad Sci U S A (2009) 1.58
Markers of autophagy are downregulated in failing human heart after mechanical unloading. Circulation (2009) 1.48
Premature aging in mice activates a systemic metabolic response involving autophagy induction. Hum Mol Genet (2008) 1.38
Lamin A/C speckles mediate spatial organization of splicing factor compartments and RNA polymerase II transcription. J Cell Biol (2002) 1.29
Prevalence of desmin mutations in dilated cardiomyopathy. Circulation (2007) 1.28
A role for nuclear lamins in nuclear envelope assembly. J Cell Biol (2001) 1.27
Desmin-related cardiomyopathy: an unfolding story. Am J Physiol Heart Circ Physiol (2011) 1.24
Hereditary muscular dystrophies and the heart. Neuromuscul Disord (2010) 1.21
Temsirolimus activates autophagy and ameliorates cardiomyopathy caused by lamin A/C gene mutation. Sci Transl Med (2012) 1.19
Myostatin blockade improves function but not histopathology in a murine model of limb-girdle muscular dystrophy 2C. Muscle Nerve (2008) 1.17
Pre-Lamin A processing is linked to heterochromatin organization. J Cell Biochem (2007) 1.14
Rapamycin ameliorates dystrophic phenotype in mdx mouse skeletal muscle. Mol Med (2011) 1.09
Involvement of PI3K/Akt/TOR pathway in stretch-induced hypertrophy of myotubes. Muscle Nerve (2010) 1.08
Mammalian target of rapamycin: biological function and target for novel anticancer agents. Am J Health Syst Pharm (2010) 1.07
Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy. Circ Res (2009) 1.01
Cerebral protein synthesis. II. Instability of cerebral messenger ribonucleic acid-ribosome complexes. J Biol Chem (1968) 1.00
Attenuated hypertrophic response to pressure overload in a lamin A/C haploinsufficiency mouse. J Mol Cell Cardiol (2009) 0.99
Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans. Heart (2000) 0.96
Inflammatory changes in infantile-onset LMNA-associated myopathy. Neuromuscul Disord (2011) 0.95
Single bout of running exercise changes LC3-II expression in rat cardiac muscle. Biochem Biophys Res Commun (2011) 0.93
mTOR inhibition: the learning curve in kidney transplantation. Transpl Int (2010) 0.91
Autophagic response to a single bout of moderate exercise in murine skeletal muscle. J Physiol Biochem (2011) 0.88
Fibrosis inhibition and muscle histopathology improvement in laminin-alpha2-deficient mice. Muscle Nerve (2010) 0.85
Molecular basis of different outcomes for drug-eluting stents that release sirolimus or tacrolimus. Curr Opin Drug Discov Devel (2010) 0.81
Role and relation of p70 S6 and extracellular signal-regulated kinases in the phenotypic changes of hypertrophy of cardiac myocytes. Jpn Circ J (2000) 0.79
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature (2009) 19.56
Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science (2005) 11.31
Extension of murine life span by overexpression of catalase targeted to mitochondria. Science (2005) 10.11
Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration. Nature (2002) 8.45
Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet (2006) 6.71
Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev (2006) 6.62
Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest (2009) 5.66
Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci (2010) 5.54
mTOR is a key modulator of ageing and age-related disease. Nature (2013) 5.40
Substrate-specific activation of sirtuins by resveratrol. J Biol Chem (2005) 5.28
LMNA mutations in atypical Werner's syndrome. Lancet (2003) 4.81
Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature (2011) 4.48
Sirtuins in aging and age-related disease. Cell (2006) 3.95
Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics (2003) 3.84
Histone H4 lysine 16 acetylation regulates cellular lifespan. Nature (2009) 3.83
Rapamycin slows aging in mice. Aging Cell (2012) 3.76
Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS One (2010) 3.62
Yeast life span extension by depletion of 60s ribosomal subunits is mediated by Gcn4. Cell (2008) 3.58
Mitochondrial point mutations do not limit the natural lifespan of mice. Nat Genet (2007) 3.53
mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome. Science (2013) 3.41
Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol (2004) 3.20
Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J Biol Chem (2010) 3.16
A molecular mechanism of chronological aging in yeast. Cell Cycle (2009) 3.12
Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab (2010) 3.07
Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic Biol Med (2006) 3.04
Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circ Res (2011) 2.99
Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation (2009) 2.96
Lifespan extension in Caenorhabditis elegans by complete removal of food. Aging Cell (2006) 2.95
The TOR pathway comes of age. Biochim Biophys Acta (2009) 2.83
DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice. Nat Genet (2008) 2.77
Proteasomal regulation of the hypoxic response modulates aging in C. elegans. Science (2009) 2.62
Replicative and chronological aging in Saccharomyces cerevisiae. Cell Metab (2012) 2.56
Werner and Hutchinson-Gilford progeria syndromes: mechanistic basis of human progeroid diseases. Nat Rev Mol Cell Biol (2007) 2.56
An Aging Interventions Testing Program: study design and interim report. Aging Cell (2007) 2.54
Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study. Lancet Oncol (2005) 2.40
Mitochondrial targeted antioxidant Peptide ameliorates hypertensive cardiomyopathy. J Am Coll Cardiol (2011) 2.40
Leukocyte telomere length predicts cancer risk in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (2007) 2.39
Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction. Aging Cell (2014) 2.35
Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis. Proc Natl Acad Sci U S A (2009) 2.33
Quantitative evidence for conserved longevity pathways between divergent eukaryotic species. Genome Res (2008) 2.32
Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in Caenorhabditis elegans. Aging Cell (2008) 2.32
Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus (2010) 2.30
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med (2007) 2.23
DNA fingerprinting abnormalities can distinguish ulcerative colitis patients with dysplasia and cancer from those who are dysplasia/cancer-free. Am J Pathol (2003) 2.22
A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Proc Natl Acad Sci U S A (2004) 2.17
Genetic mouse models of extended lifespan. Exp Gerontol (2003) 2.15
Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology (2008) 2.14
Recent developments in yeast aging. PLoS Genet (2007) 2.13
Mitochondria and tumor progression in ulcerative colitis. J Natl Cancer Inst (2013) 2.09
Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat Genet (2002) 2.08
Lifespan extension in genetically modified mice. Aging Cell (2009) 1.98
Genes determining yeast replicative life span in a long-lived genetic background. Mech Ageing Dev (2005) 1.96
Progeria syndromes and ageing: what is the connection? Nat Rev Mol Cell Biol (2010) 1.93
Increased life span due to calorie restriction in respiratory-deficient yeast. PLoS Genet (2005) 1.86
Housing density does not influence the longevity effect of calorie restriction. J Gerontol A Biol Sci Med Sci (2005) 1.85
When lamins go bad: nuclear structure and disease. Cell (2013) 1.84
Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria. J Gerontol A Biol Sci Med Sci (2008) 1.83
The role of mTOR signaling in controlling mammalian life span: what a fungicide teaches us about longevity. J Gerontol A Biol Sci Med Sci (2010) 1.77
PI3 kinase signaling is required for retrieval and extinction of contextual memory. Nat Neurosci (2005) 1.76
A method for high-throughput quantitative analysis of yeast chronological life span. J Gerontol A Biol Sci Med Sci (2008) 1.76
Age- and calorie-independent life span extension from dietary restriction by bacterial deprivation in Caenorhabditis elegans. BMC Dev Biol (2008) 1.75
Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis. Mol Cell Biol (2007) 1.74
Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. Genes Dev (2006) 1.73
Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell (2013) 1.71
Measuring replicative life span in the budding yeast. J Vis Exp (2009) 1.68
Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits. PLoS One (2011) 1.62
Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell (2013) 1.60
Glutamate cysteine ligase modifier subunit deficiency and gender as determinants of acetaminophen-induced hepatotoxicity in mice. Toxicol Sci (2007) 1.60
Elevated proteasome capacity extends replicative lifespan in Saccharomyces cerevisiae. PLoS Genet (2011) 1.52
Sildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy. Proc Natl Acad Sci U S A (2010) 1.48
Cardiac aging in mice and humans: the role of mitochondrial oxidative stress. Trends Cardiovasc Med (2009) 1.48
Localization and characterization of a novel secreted protein SCUBE1 in human platelets. Cardiovasc Res (2006) 1.48
Advancing a clinically relevant perspective of the clonal nature of cancer. Proc Natl Acad Sci U S A (2011) 1.47
Age-dependent cardiomyopathy in mitochondrial mutator mice is attenuated by overexpression of catalase targeted to mitochondria. Aging Cell (2010) 1.47
Mitochondria and cardiovascular aging. Circ Res (2012) 1.46
Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety. Nat Neurosci (2011) 1.46
The transcriptome and its translation during recovery from cell cycle arrest in Saccharomyces cerevisiae. Mol Cell Proteomics (2003) 1.45
Shortest-path network analysis is a useful approach toward identifying genetic determinants of longevity. PLoS One (2008) 1.45
Disruption of protein kinase A in mice enhances healthy aging. PLoS One (2009) 1.43